OpenBilldrug price receipt

NADAC week of 2026-10-14

FLUPHENAZINE 2.5 MG TABLET

For 30 tablets

Pharmacies pay

$6.71 filed

30 × $0.22373 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$66.00 filed

30 × $2.19993 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

9.8× estimated

Medicare paid 9.8× what pharmacies pay.

Part D averages every strength and form sold under “Fluphenazine HCl*” / “Fluphenazine HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$12.72 estimated

$6.71 + $1.01 (15%) + $5.00 fee per fill = $12.72

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

FLUPHENAZINE 2.5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as fluphenazine hydrochloride, under the trade name “Fluphenazine Hydrochoride”.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 15 labelers (the companies named on the label) for its NDCs, among them Lannett Company, Inc., Upsher-Smith Laboratories,LLC and Major Pharmaceuticals.

FDA’s Established Pharmacologic Class for it is Phenothiazine.

The NADAC file of 2026-10-14 prices it under 17 NDCs (National Drug Codes); the FDA directory lists 16 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $6.71 for 30 tablets (30 × $0.22373 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 15 labelers

LabelerNDCsPharmacies pay per unit
Upsher-Smith Laboratories,LLC2$0.22373 per EA filed
ANI Pharmaceuticals, Inc.1$0.22373 per EA filed
Ajanta Pharma USA Inc.1$0.22373 per EA filed
Alembic Pharmaceuticals Inc.1$0.22373 per EA filed
Amneal Pharmaceuticals NY LLC1$0.22373 per EA filed
Aurobindo Pharma Limited1$0.22373 per EA filed
AvPAK1$0.22373 per EA filed
Camber Pharmaceuticals, Inc.1$0.22373 per EA filed
Chartwell RX, LLC1$0.22373 per EA filed
Dr. Reddy’s Laboratories Inc.1$0.22373 per EA filed
Glenmark Pharmaceuticals Inc., USA1$0.22373 per EA filed
Lannett Company, Inc.1$0.22373 per EA filed
Major Pharmaceuticals1$0.22373 per EA filed
Rising Pharma Holdings, Inc.1$0.22373 per EA filed
Sun Pharmaceutical Industries, Inc.1$0.22373 per EA filed
Not listed as a package in the FDA directory1$0.22373 per EA filed
All 17 NDCs, with labeler and price
  • 00527-1789-01 · Lannett Company, Inc. · $0.22373 per EA · eff. 2026-09-23 filed
  • 00832-6004-11 · Upsher-Smith Laboratories,LLC · $0.22373 per EA · eff. 2026-09-23 filed
  • 00904-7158-61 · Major Pharmaceuticals · $0.22373 per EA · eff. 2026-09-23 filed
  • 16571-0890-09 · Rising Pharma Holdings, Inc. · $0.22373 per EA · eff. 2026-09-23 filed
  • 24979-0137-01 · Upsher-Smith Laboratories, LLC · $0.22373 per EA · eff. 2026-09-23 filed
  • 27241-0254-01 · Ajanta Pharma USA Inc. · $0.22373 per EA · eff. 2026-09-23 filed
  • 31722-0385-01 · Camber Pharmaceuticals, Inc. · $0.22373 per EA · eff. 2026-09-23 filed
  • 43598-0035-01 · Dr. Reddy’s Laboratories Inc. · $0.22373 per EA · eff. 2026-09-23 filed
  • 50268-0367-11 · not listed as a package in the FDA directory · $0.22373 per EA · eff. 2026-09-23 filed
  • 50268-0367-15 · AvPAK · $0.22373 per EA · eff. 2026-09-23 filed
  • 51672-4234-01 · Sun Pharmaceutical Industries, Inc. · $0.22373 per EA · eff. 2026-09-23 filed
  • 59651-0687-01 · Aurobindo Pharma Limited · $0.22373 per EA · eff. 2026-09-23 filed
  • 62135-0416-90 · Chartwell RX, LLC · $0.22373 per EA · eff. 2026-09-23 filed
  • 62332-0789-31 · Alembic Pharmaceuticals Inc. · $0.22373 per EA · eff. 2026-09-23 filed
  • 68462-0336-01 · Glenmark Pharmaceuticals Inc., USA · $0.22373 per EA · eff. 2026-09-23 filed
  • 69238-1679-01 · Amneal Pharmaceuticals NY LLC · $0.22373 per EA · eff. 2026-09-23 filed
  • 70954-0274-10 · ANI Pharmaceuticals, Inc. · $0.22373 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name fluphenazine hydrochloride with FLUPHENAZINE 2.5 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
FLUPHENAZINE 1 MG TABLET
generic · tablet, film coated / tablet
$0.2128 per EA filed
eff. 2026-09-23
$2.19993 per EA filed
Part D 2024 average
FLUPHENAZINE 2.5 MG TABLET this page
generic · tablet, film coated / tablet
$0.22373 per EA filed
eff. 2026-09-23
$2.19993 per EA filed
Part D 2024 average
FLUPHENAZINE 5 MG TABLET
generic · tablet, film coated / tablet
$0.14825 per EA filed
eff. 2026-09-23
$2.19993 per EA filed
Part D 2024 average
FLUPHENAZINE 10 MG TABLET
generic · tablet, film coated / tablet
$0.43085 per EA filed
eff. 2026-09-23
$2.19993 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 17 NDCs’ NADAC prices is $0.22373 per EA filed.

Of the 32 other products in FDA’s Phenothiazine class priced per EA, 22 have a higher middle NADAC price and 10 a lower one. The one in the middle is TRIFLUOPERAZINE 1 MG TABLET, at $0.42513 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $66.00 for 30 tablets, at an average of $2.19993 per EA in 2024 (2024-01-01 to 2024-12-31) for “Fluphenazine HCl*” and “Fluphenazine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 220,188 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for FLUPHENAZINE 2.5 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Fluphenazine HCl* / Fluphenazine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. All 77 NADAC NDCs the name join matched to it have an FDA route including ORAL. 7 of the 77 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code).